Everett Cunningham - 25 Feb 2022 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Reporting relationship: Chief Commercial Officer
Issuer ticker: EXAS
Reported as of: 25 Feb 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Mar 2022, 17:25:19 UTC
Prior SEC filing: 05 Nov 2021
Next SEC filing: 13 Oct 2022
Source filing: View source filing
Reporting owner signature: /s/ Everett Cunningham by Mark R. Busch, attorney-in-fact

Key filing fact

Everett Cunningham filed Form 4 for EXACT SCIENCES CORP (EXAS) on 01 Mar 2022.

Key facts

This page summarizes Everett Cunningham's Form 4 filing for EXACT SCIENCES CORP (EXAS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 01 Mar 2022, 17:25.

Change

Previous filing in this sequence was filed on 05 Nov 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EXAS transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +30,711
Change %
Price: $0.000000
Shares after: 30,711
Date: 25 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,711
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of common stock.

Footnote F2

These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.

Footnote F3

In addition to the shares of Restricted Stock Units reported on this Form 4, Mr. Cunningham holds, in the aggregate, 120,726 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.